As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Merck & Co., Inc.: CTC LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Point72 Asset Management L.P., Man Group plc, Maven Securities LTD, Millennium Management LLC, Laurion Capital Management LP, Jefferies Financial Group Inc., Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Berkley W R Corp, Lido Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, SIH Partners LLLP, HAP Trading LLC, Concourse Financial Group Securities Inc., Marshall Wace LLP, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, Wells Fargo & Company MN, JPMorgan Chase & Co., Mirae Asset Securities USA Inc., Simplex Trading LLC, Twin Tree Management LP, Delta Accumulation LLC, Marathon Trading Investment Management LLC, Allianz Asset Management GmbH, Wolverine Asset Management LLC, Gladius Capital Management LP, Genus Capital Management Inc., XY Capital Ltd, IMC Chicago LLC, Insight Advisors LLC PA, Revolve Wealth Partners LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.